Literature DB >> 15156990

Multifactorial refractory heterotopic ossification.

Andrew J L Gear1, Claire Buckley, Fred Kaplan, Alan Vanbeek.   

Abstract

Ectopic bone formation or "heterotopic ossification" can follow surgery, trauma, or neurologic injury, but the process is usually self-limited, localized to the site of injury, and responds to surgical treatment when necessary. Aggressive, systemic forms of heterotopic ossification exist that generate lesions that often resist surgical treatment and produce a high rate of recurrence. These entities typically manifest during infancy as genetic syndromes such as fibrodysplasia ossificans progressiva or progressive osseous heteroplasia. The authors describe a case of aggressive, systemic heterotopic ossification in an adult that followed a motor vehicle accident and multiple surgeries. The patient developed a large nonhealing wound around a focus of ectopic bone. Skin grafts failed as a result of the recurrence of ectopic bone, and the patient eventually required aggressive debridement and delayed rotational flap closure. A brief review of the clinical features and surgical treatment of heterotopic ossification is outlined.

Entities:  

Mesh:

Year:  2004        PMID: 15156990     DOI: 10.1097/01.sap.0000099624.04554.63

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  3 in total

1.  Management of pelvic heterotopic ossification post-myocutaneous flap reconstruction of a sacral pressure ulcer.

Authors:  Colin W McInnes; Richard Ak Reynolds; Jugpal S Arneja
Journal:  Can J Plast Surg       Date:  2011

2.  Establishment of heterotopic ossification via sharp instrument injury in rats.

Authors:  J-C Xu; G-H Wu; L-L Zhou; X-J Yang; J-T Liu
Journal:  J Musculoskelet Neuronal Interact       Date:  2017-03-01       Impact factor: 2.041

3.  Case Report: Two Monochorionic Twins With a Critically Different Course of Progressive Osseus Heteroplasia.

Authors:  Antonio José Justicia-Grande; Jose Gómez-Ríal; Irene Rivero-Calle; Sara Pischedda; María José Curras-Tuala; Alberto Gómez-Carballa; Miriam Cebey-López; Jacobo Pardo-Seco; Roberto Méndez-Gallart; María José Fernández-Seara; Antonio Salas; Federico Martinón-Torres
Journal:  Front Pediatr       Date:  2021-06-23       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.